Comparing the fixed combination dorzolamide–timolol (Cosopt®) to concomitant administration of 2% dorzolamide (Trusopt®) and 0·5% timolol – a randomized controlled trial and a replacement study
暂无分享,去创建一个
B. Francis | D. Minckler | S. Berke | M. Ehrenhaus | L. T. Du | L. T. Du
[1] M. B. Shields,et al. A comparison of dorzolamide-timolol combination versus the concomitant drugs. , 2000, American journal of ophthalmology.
[2] D. Gieser,et al. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. , 1998, Ophthalmology.
[3] E. Snyder,et al. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. , 1998, Ophthalmology.
[4] E. Snyder,et al. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. , 1998, Ophthalmology.
[5] S. Owens,et al. Comparison of the safety and efficacy of the fixed combination of dorzolamide/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study , 1998 .
[6] E. Strahlman,et al. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group. , 1995, Archives of ophthalmology.
[7] D. Epstein,et al. Levobunolol and betaxolol. A double-masked controlled comparison of efficacy and safety in patients with elevated intraocular pressure. , 1988, Ophthalmology.
[8] R. Allen,et al. A double-masked comparison of betaxolol vs timolol in the treatment of open-angle glaucoma. , 1986, American journal of ophthalmology.